MOST NOTEWORTHY:

• Jefferies downgraded shares of FBR Capital Markets (NASDAQ: FBCM) to Hold from Buy and lowered their target to $9 from $14 as they believe the company's investment banking activity will continue to be limited due to the current market conditions for capital raising.
  
• Wachovia downgraded shares of Altus Pharmaceuticals (NASDAQ: ALTU) to Market Perform from Outperform following Genentech's (NYSE: DNA) return of all North American marketing rights to ALTU-238.
  
• Energias de Portugal (OTC: EDPFY) was lowered to Hold from Buy at Citigroup, as they see no valuation catalysts in the near-term.

• JP Morgan removed Teekay LNG (NYSE: TGP) from its Focus List.
  
• Goldman downgraded ORIX Corp. (NYSE: IX) to Neutral from Buy.
  
• Friedman Billings downgraded VeraSun Energy (NYSE: VSE) to Market Perform from Outperform.

Analyst downgrades: FBCM, ALTU and EDPFY originally appeared on BloggingStocks on Thu, 20 Dec 2007 11:47:00 EST. Please see our terms for use of feeds.

MOST NOTEWORTHY:

• Cantor initiated shares of FreeSeas (NASDAQ: FREE) with a Buy rating and $10 target, as they expect the company to benefit from the continued strength in the dry bulk market.
  
• JP Morgan resumed coverage of Nektar (NASDAQ: NKTR) with an Overweight rating, as they view weakness from the discontinuation of Exubera as a buying opportunity given the company's base royalty business and pipeline opportunities.
  
• Altus Pharmaceuticals (NASDAQ: ALTU) was initiated with a Buy rating and $19 target at Jefferies. The firm expects news flow from the company's two lead products over the next 6-12 months that should act as catalysts.
  
• AbitibiBowater (NYSE: ABH) was initiated with a Sell rating and $18 target at Banc of America, as they are cautious on newsprint trends; the firm recommends reducing existing positions.

• Caris initiated Collective Brands (NYSE: PSS) with an Average rating and $18 target and Under Armour (NYSE: UA) with an Above Average rating.
  
• Stifel started shares of Patriot Coal (NYSE: PCX) with a Hold rating.
  
• PetroChina (NYSE: PTR) was initiated with a Sell rating at Goldman.

Analyst inititations: FREE, NKTR, ALTU and ABH originally appeared on BloggingStocks on Fri, 09 Nov 2007 11:20:00 EST. Please see our terms for use of feeds.

MOST NOTEWORTHY:

• Jefferies assumed coverage of International Game Tech (NYSE: IGT) with a Buy rating and $47 target citing an attractive risk/reward.

• Big 5 Sporting Goods (NASDAQ: BGFV) was started with a Sector Performer rating and $33 target at CIBC, expecting shares to be driven by an operating margin recover and improving cash flows.

• CVS/Caremark Corp (NYSE: CVS) was reinstated with an Overweight rating at Lehman Brothers and resumed with an Overweight rating at Morgan Stanley.

• JP Morgan believes the rough environment, growing competition and valuation warrants IHOP Corp (NYSE: IHP) to start with a Neutral rating.

• B. Riley initiated shares of United Online, Inc (NASDAQ: UNTD) with a Buy rating and $18 target.

• Bear Stearns started T-3 Energy Services, Inc (NASDAQ: TTES) with an Outperform rating and $32 target.

• Morgan Stanley initiated shares of Vanda Pharmaceuticals Inc (NASDAQ: VNDA) with an Overweight rating and $29 target.

• American Technology initiated shares of Bankrate, Inc (NASDAQ: RATE) with a Buy rating and $48 target.

• Altus Pharmaceuticals Inc (NASDAQ: ALTU) was initiated with an Outperform rating and $20 fair value estimate at Leerink Swann.

Analyst initiations 4-30-07: BGFV, CVS, IGT, IHP and RATE originally appeared on BloggingStocks on Mon, 30 Apr 2007 11:17:00 EST. Please see our terms for use of feeds.

MOST NOTEWORTHY:

• FTN Midwest initiated shares of Ethan Allen Interiors Inc (NYSE: ETH), Pier 1 Imports (NYSE: PIR) and Bed Bath & Beyond Inc (NASDAQ: BBBY) with Neutral ratings and Williams-Sonoma Inc (NYSE: WSM) with a Buy rating.

• BMO Capital started Bronco Drilling Co (NASDAQ: BRNC), Pioneer Drilling Co (AMEX: PDC) and Union Drilling, IncNASDAQ: UDRL) with Outperform ratings.

• CIBC started Chemtura Corp (NYSE: CEM) with a Sector Underperformer rating and $11 target on valuation.

• C.E. Unterberg started Altus Pharmaceuticals Inc (NASDAQ: ALTU) with a Buy rating and $12 target, believing the company's efforts to develop the first juvenile formulation of a pancreatic enzyme will be a key growth driver.

Analyst initiations 4-27-07: BBBY, ETH, PIR and WSM originally appeared on BloggingStocks on Fri, 27 Apr 2007 11:26:00 EST. Please see our terms for use of feeds.